Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

MultiMedRx vs RxSaludable

MultiMedRx
Graded #394

Lower grade

vs+5.399999999999999
RxSaludable
Graded #264

Higher grade

The verdict

RxSaludable takes it — 63/100 to 57.6/100.

RxSaludable grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. RxSaludable is a Spanish-language GLP-1 weight-loss telehealth service (atencion en espanol) offering compounded semaglutide from $99 the first month ($179/mo after) and tirzepatide from $189 the first…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueRxSaludable +5
45
50
Dose & formulationRxSaludable +24
53
77
Clinical oversightRxSaludable +3
79
82
Labs & monitoringEven
53
53
FulfillmentRxSaludable +9
67
76
Contract termsMultiMedRx +29
49
20
MultiMedRx · left barRxSaludable · right bar

The numbers

MetricMultiMedRxRxSaludable
WeighScore57.6/10063/100
GradeCC
Scorecard rank#394#264
SemaglutideNot disclosed$179/mo (compounded)
TirzepatideNot disclosed$269/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
MultiMedRx

Graded #394 · C

Strengths

  • Legal entity disclosed (MMRX MultiMedRx LLC) — uncommon transparency
  • Two physical addresses listed: Newport Beach, CA and Reno, NV
  • LegitScript seal present
  • Features brand-name GLP-1s (Ozempic, Wegovy, Zepbound) — rare in a mostly compounded-only field
  • Broader cardiometabolic menu (metformin, testosterone, HRT) alongside GLP-1

Where it loses points

  • No Mounjaro or Foundayo in the brand-name lineup (only Ozempic, Wegovy, Zepbound)
  • Monthly GLP-1 pricing isn't published — gated behind the consultation
  • $100 consultation fee adds friction; many peers bundle it into the medication price
  • Per-state availability not listed; only CA and NV offices disclosed
  • Whether compounded GLP-1 is offered isn't clear — verify during intake
RxSaludable

Graded #264 · C

Strengths

  • Spanish-language platform with Spanish-speaking, U.S.-licensed providers — a genuine gap in GLP-1 telehealth
  • Compounded semaglutide $99 first month ($179/mo after) and tirzepatide $189 first month; same price at every dose, no membership fee
  • LegitScript-certified (#50274281); free expedited shipping; named obesity-medicine physicians
  • Same-day doctor visits, 24/7 support, FSA/HSA eligible, cancel anytime

Where it loses points

  • Ongoing prices ($179-289/mo) are mid-range once the first-month intro ends
  • Doesn't name its compounding pharmacy partners (generic 'certified pharmacies')
  • No legal entity name or explicit state-coverage list published on the site
  • Compounded GLP-1s are not FDA-approved (the site discloses this)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard